- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
research use only
Cat.No.S3648
| Related Targets | PD-1/PD-L1 CXCR STING AhR CD markers Interleukins Anti-infection Antioxidant COX Histamine Receptor |
|---|---|
| Other Immunology & Inflammation related Products | Cl-amidine Tempol Anti-mouse CD8α-InVivo Tranilast Sinomenine Geniposidic acid GI254023X (GI4023) CORM-3 Bestatin (Ubenimex) Acacetin |
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| ARPE-19 cells | Function assay | 1 μM | Inhibition of TBK1 by Amlx (1 µM) reduces HG-induced mitophagic flux | |||
| HCT-116 | Function assay | 100 μM | 48 h | Amlexanox stimulates expression from a NMD reporter vector. | ||
| PC3 | Function assay | 20 nM, 100 nM, 1μM and 5 μM | leads to dosage-dependent downregulation of EMT-inducing transcriptional factors Zeb1 and N-cadherin, and upregulation of epithelial-specific protein E-cadherin | |||
| DU145 | Function assay | 20 nM, 100 nM, 1μM and 5 μM | leads to dosage-dependent downregulation of EMT-inducing transcriptional factors Zeb1 and N-cadherin, and upregulation of epithelial-specific protein E-cadherin | |||
| U87 | Proliferation assay | 0-300 μM | 24, 48, 72 and 96 h | The IC50 values for 72 h of amlexanox treatment were approximately 140 μM in U87 cells. | ||
| U251 | Proliferation assay | 0-300 μM | 24, 48, 72 and 96 h | The IC50 values for 72 h of amlexanox treatment were approximately 120 μM in U251 cells. | ||
| NIH 3T3 cells | Function assay | 1 mM or 0.375 mM | 24 h | Cells exhibited a dramatic change in their morphology that included a larger and more flattened phenotype and often displayed long processes that are stable for at least 10 days | ||
| HUVEC | Function assay | 1 mM or 0.375 mM | 24 h | modify cell morphology | ||
| Swiss 3T3 | Function assay | 1 mM | 10-360 min | Amlexanox was able to stimulate the tyrosine phosphorylation of cortactin in a rapid and sustained manner. | ||
| Click to View More Cell Line Experimental Data | ||||||
|
In vitro |
DMSO
: 59 mg/mL
(197.79 mM)
Ethanol : 2 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 298.29 | Formula | C16H14N2O4 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 68302-57-8 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | CHX-3673, Amoxanox, AA-673 | Smiles | CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N | ||
| Targets/IC50/Ki |
TBK1
IKK-ε
|
|---|---|
| In vitro |
Dose-response relationship of amlexanox inhibition of IKK-ɛ and TBK1 activity as determined by MBP phosphorylation showing an IC50 of approximately 1-2 μM. This compound also blocks the activity of TBK1 at approximately the same concentrations but has no effect on IKK-α or IKK-β and at these concentrations do not block any other kinases from a broad panel representing most kinase families. Inhibition of IKK-ɛ or TBK1 by this chemical is competitive for its substrate ATP, indicating that it interacts with the enzymes in the ATP-binding site. It increases the phosphorylation of TBK1 at Ser172 in 3T3-L1 adipocytes and blocks polyinosinic:polycytidylic acid (poly I:C)-stimulated phosphorylation of interferon responsive factor-3 (IRF3), a presumed substrate of IKK-ɛ and TBK1.
|
| In vivo |
Treatment of obese mice with amlexanox elevates energy expenditure through increased thermogenesis, producing weight loss, improves insulin sensitivity and decreases steatosis.
|
References |
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Western blot | IKKε / TBK1 / IKKβ MMP2 / MMP9 IKBKE / MST1 / MST2 / p-MST / LAST1 / LAST2 / p-YAP1 / YAP1 / Axl / c-Myc / Cyr61 p-p65 / p-IκBα / S100A13 |
|
23396211 |
| Growth inhibition assay | Cell viability |
|
29048430 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.